IDEXX Laboratories, Inc. (IDXX)

Market Cap	34.38B
Revenue (ttm)	3.84B
Net Income (ttm)	866.24M
Shares Out	81.88M
EPS (ttm)	10.36
PE Ratio	40.53
Forward PE	35.92
Dividend	n/a
Ex-Dividend Date	n/a

Volume	407,953
Open	421.50
Previous Close	420.91
Day's Range	418.95 - 424.05
52-Week Range	404.74 - 583.39
Beta	1.36
Analysts	Buy
Price Target	545.29 (+29.88%)
Earnings Date	Oct 31, 2024

About IDXX

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnos...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Jun 21, 1991
• Employees: 11,000
• Stock Exchange: NASDAQ
• Ticker Symbol: IDXX
• Website: https://www.idexx.com

Financial Performance

In 2023, IDEXX Laboratories's revenue was $3.66 billion, an increase of 8.72% compared to the previous year's $3.37 billion. Earnings were $845.04 million, an increase of 24.44%.

Analyst Forecast

According to 7 analysts, the average rating for IDXX stock is "Buy." The 12-month stock price forecast is $545.29, which is an increase of 29.88% from the latest price.

Price Target

$545.29

(29.88% upside)

Analyst Consensus: Buy